Company intelligence
Neuromics
Neuromics is a bioreagents company providing human cells, defined media, adherent coatings, FBS, and purification tools
About Neuromics
We specialize in providing reagents and methods for the Neuroscience Research Community. As a natural extension, we are growing our catalog to serve Diabetes-Obesity, Immune Response, Apoptosis Detection, and Cancer Researchers. Our offerings include products for optimizing cell-based assays for basic research and drug discovery. These include primary cells, iPSC-derived cells, cells lines, 3D models and more. In addition to human cells, we also offer primary antibodies, specialized media, FBS & other sera, recombinant proteins, and more. Neuromics is also a US distributor for IBA Lifesciences. We offer their entire portfolio of cutting-edge protein purification products. Our unique value is based on providing reagents that are thoroughly tested and characterized. Our reagents need to work in your unique application.
Verified activity
Signals from Neuromics
3 published signals
Presence & Recognition
Neuromics employee George Ackerman, Ph.D., JD., Advocate, is sharing his quest to find a cure or Parkinson's disease.
Reported by Pete Shuster
Research & Knowledge
Neuromics Primary Human Neurons (HNC001), Brain Microglia (HBMCs001), and AlphaBioCoat™ supporting non-cancerous neurotoxicity benchmarking in this multi-virus screening platform were published in Molecular Therapy: Oncology by the Daelemans Lab and the research team at KU Leuven / Rega Institute.
Reported by Pete Shuster
Research & Knowledge
Neuromics Primary Human Neurons (HNC001), Brain Microglia (HBMCs001), and AlphaBioCoat™ supporting non-cancerous neurotoxicity benchmarking in this multi-virus screening platform were published in Molecular Therapy: Oncology by Prof. Dirk Daelemans and the research team at KU Leuven / Rega Institute.
Reported by Neuromics